BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33189527)

  • 1. Prognostic classifier for predicting biochemical recurrence in localized prostate cancer patients after radical prostatectomy.
    Carrion A; Ingelmo-Torres M; Lozano JJ; Montalbo R; D'Anna M; Mercader C; Velez E; Ribal MJ; Alcaraz A; Mengual L
    Urol Oncol; 2021 Aug; 39(8):493.e17-493.e25. PubMed ID: 33189527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
    Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
    Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
    Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF
    Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Cdc20 in clinically localized prostate cancer: Relation to high Gleason score and biochemical recurrence after laparoscopic radical prostatectomy.
    Mao Y; Li K; Lu L; Si-Tu J; Lu M; Gao X
    Cancer Biomark; 2016; 16(3):351-8. PubMed ID: 26889981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
    Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
    Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical recurrence after radical prostatectomy with or without pelvic lymphadenectomy in Korean men with high-risk prostate cancer.
    Ku JH; Jeong CW; Park YH; Cho MC; Kwak C; Kim HH
    Jpn J Clin Oncol; 2011 May; 41(5):656-62. PubMed ID: 21430020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The meaning of PSA progression after radical prostatectomy. Preliminary results].
    Luján Galán M; Pascual Mateo C; Rodríguez García N; Chiva Robles V; Escalera Almendros C; Angulo Cuesta J; Berenguer Sánchez A
    Actas Urol Esp; 2006 Apr; 30(4):353-8. PubMed ID: 16838606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathway of isolated seminal vesicle invasion has a different impact on biochemical recurrence after radical prostatectomy and pelvic lymphadenectomy.
    Galosi AB; Milanese G; Montesi L; Cimadamore A; Franzese C; Palagonia E; Chiacchio G; Castellani D
    Urol Oncol; 2023 Jun; 41(6):293.e9-293.e14. PubMed ID: 37142452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age on biochemical recurrence after radical prostatectomy.
    Ozden C; Aktas BK; Bulut S; Erbay G; Tagci S; Gokkaya CS; Baykam MM; Memis A
    Kaohsiung J Med Sci; 2017 Feb; 33(2):91-95. PubMed ID: 28137417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of positive surgical margins in patients with organ-confined prostate cancer results in biochemical recurrence at a similar rate to that in patients with extracapsular extension and PSA ≤ 10 ng/ml.
    Eminaga O; Hinkelammert R; Titze U; Abbas M; Eltze E; Bettendorf O; Semjonow A
    Urol Oncol; 2014 Jan; 32(1):32.e17-25. PubMed ID: 23434425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical factors associated with biochemical recurrence of prostate cancer with seminal vesicle invasion followed by robot-assisted radical prostatectomy: a retrospective multicenter cohort study in Japan (the MSUG94 group).
    Kawase M; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
    J Robot Surg; 2023 Aug; 17(4):1609-1617. PubMed ID: 36928750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy.
    Secin FP; Bianco FJ; Vickers AJ; Reuter V; Wheeler T; Fearn PA; Eastham JA; Scardino PT
    Cancer; 2006 Jun; 106(11):2369-75. PubMed ID: 16649221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical recurrence-free conditional probability after radical prostatectomy: A dynamic prognosis.
    García-Barreras S; Sanchez-Salas R; Mejia-Monasterio C; Muttin F; Secin F; Dell'Oglio P; Nunes-Silva I; Srougi V; Barret E; Rozet F; Prapotnich D; Cathelineau X
    Int J Urol; 2019 Jul; 26(7):725-730. PubMed ID: 31001870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of biochemical recurrence after radical prostatectomy in an Afro-Caribbean population in Guadeloupe (French West Indies).
    Brureau L; Emeville E; Multigner L; Blanchet P
    Prog Urol; 2018 Jun; 28(8-9):442-449. PubMed ID: 29789237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The factors predicting biochemical recurrence in patients with radical prostatectomy.
    Koca O; Ün S; Türk H; Zorlu F
    Arch Ital Urol Androl; 2016 Jan; 87(4):270-5. PubMed ID: 26766796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do Second Primary Cancers Affect the Risk of Biochemical Recurrence in Prostate Cancer Patients Undergoing Radical Prostatectomy? A Propensity Score-Matched Analysis.
    Kang M; Jung JW; Oh JJ; Lee S; Hong SK; Lee SE; Byun SS
    Clin Genitourin Cancer; 2016 Aug; 14(4):e363-9. PubMed ID: 27105723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate Cancer.
    Hegde JV; Veruttipong D; Said JW; Reiter RE; Steinberg ML; King CR; Kishan AU
    Urology; 2017 Sep; 107():171-177. PubMed ID: 28552819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
    Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
    J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt Activation Correlates with Snail Expression and Potentially Determines the Recurrence of Prostate Cancer in Patients at Stage T2 after a Radical Prostatectomy.
    Chen WY; Hua KT; Lee WJ; Lin YW; Liu YN; Chen CL; Wen YC; Chien MH
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27455254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node yield during radical prostatectomy does not impact rate of biochemical recurrence in patients with seminal vesicle invasion and node-negative disease.
    Badani KK; Reddy BN; Moskowitz EJ; Paulucci DJ; Beksac AT; Martini A; Whalen MJ; Skarecky DW; Huynh LM; Ahlering TE
    Urol Oncol; 2018 Jun; 36(6):310.e1-310.e6. PubMed ID: 29625782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.